AMGEN Inc. (AMGN)

Precedente Chiudi:

$269.38

Aprire:

$265.72

Volume 24 ore:

2.16M

Capitalizzazione di mercato:

$144.81B

Reddito:

$28.19B

Utile/perdita netta:

$6.72B

Rapporto P/E:

19.19

EPS:

14.07

Flusso di cassa netto:

$7.36B

1 W Prestazione:

+0.39%

1M Prestazione:

-4.18%

6M Prestazione:

+0.10%

1 anno Prestazione:

+13.06%

Intervallo 1D:

$265.72

$271.68

Portata 52W:

$211.71

$329.72

AMGEN Inc. Stock (AMGN) Company Profile

Nome

AMGEN Inc.

Settore

Healthcare (1191)

Industria

Drug Manufacturers - General (18)

Telefono

805-447-1000

Indirizzo

One Amgen Center Drive, Thousand Oaks, CA

Dipendente

20,800

Cinguettio

@amgen

Prossima data di guadagno

2024-05-02

Ultimi documenti SEC

AMGN's Discussions on Twitter

AMGEN Inc. Stock (AMGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-03-28	Ripresa	Raymond James	Mkt Perform
2024-02-07	Downgrade	Leerink Partners	Outperform → Market Perform
2023-12-21	Aggiornamento	Daiwa Securities	Neutral → Buy
2023-12-19	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2023-12-12	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-11-09	Iniziato	Deutsche Bank	Hold
2023-11-02	Aggiornamento	Truist	Hold → Buy
2023-10-20	Ripresa	JP Morgan	Neutral
2023-10-17	Ripresa	Morgan Stanley	Equal-Weight
2023-10-11	Ripresa	BofA Securities	Neutral
2023-09-06	Iniziato	HSBC Securities	Buy
2023-04-24	Reiterato	Oppenheimer	Outperform
2023-03-13	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-02-13	Reiterato	Truist	Buy
2022-11-18	Iniziato	Credit Suisse	Underperform
2022-10-31	Downgrade	Barclays	Equal Weight → Underweight
2022-10-11	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-05-23	Iniziato	SVB Leerink	Mkt Perform
2022-02-09	Reiterato	Barclays	Equal Weight
2022-02-09	Reiterato	Jefferies	Buy
2022-02-09	Reiterato	Morgan Stanley	Equal-Weight
2022-02-09	Reiterato	Oppenheimer	Outperform
2022-02-09	Reiterato	Wells Fargo	Equal Weight
2022-01-05	Downgrade	BofA Securities	Buy → Neutral
2021-12-09	Ripresa	Wells Fargo	Equal Weight
2021-12-06	Iniziato	Goldman	Buy
2021-11-19	Iniziato	BMO Capital Markets	Market Perform
2021-09-23	Downgrade	Daiwa Securities	Outperform → Neutral
2021-09-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-12-29	Iniziato	Daiwa Securities	Buy
2020-10-28	Iniziato	UBS	Neutral
2020-10-26	Aggiornamento	Raymond James	Mkt Perform → Outperform
2020-10-12	Aggiornamento	Truist	Hold → Buy
2020-10-09	Downgrade	Bernstein	Outperform → Mkt Perform
2020-10-09	Downgrade	Truist	Buy → Hold
2020-10-08	Downgrade	Raymond James	Outperform → Mkt Perform
2020-04-15	Ripresa	Guggenheim	Neutral
2020-03-31	Iniziato	Wolfe Research	Peer Perform
2020-03-30	Aggiornamento	Raymond James	Mkt Perform → Outperform
2020-03-05	Aggiornamento	BofA/Merrill	Neutral → Buy
2020-02-27	Iniziato	Barclays	Equal Weight
2020-01-31	Downgrade	Robert W. Baird	Neutral → Underperform
2020-01-21	Aggiornamento	Evercore ISI	In-line → Outperform
2019-12-24	Iniziato	Raymond James	Mkt Perform
2019-12-17	Ripresa	Morgan Stanley	Overweight
2019-11-12	Iniziato	SunTrust	Buy
2019-11-05	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2019-10-17	Ripresa	BofA/Merrill	Neutral
2019-08-19	Downgrade	Mizuho	Buy → Neutral
2019-05-23	Aggiornamento	Citigroup	Neutral → Buy

Mostra tutto

AMGEN Inc. Borsa (AMGN) Ultime notizie

Wall Street Breakfast: The Week Ahead

Seeking Alpha

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

Zacks Investment Research

Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

Benzinga

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

Zacks Investment Research

Better Buy: Pfizer vs. Viking Therapeutics

The Motley Fool

AMGEN Inc. Azioni (AMGN) Dati Finanziari

AMGEN Inc. (AMGN) Reddito 2024

AMGEN Inc. (AMGN) Reddito netto 2024

AMGEN Inc. (AMGN) Flusso di cassa 2024

AMGEN Inc. (AMGN) Utile per azione 2024

AMGEN Inc. Azioni (AMGN) insider trading